|
Market Closed -
Toronto S.E.
01:29:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.540 CAD | -0.62% |
|
+4.49% | +20.45% |
| 28/10 | Satellos Bioscience Inc. Announces Management Changes | CI |
| 05/10 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
Company Valuation: Satellos Bioscience Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6.794 | 36.73 | 95.65 | 89.3 | 145.1 | - | - |
| Change | - | 440.53% | 160.46% | -6.65% | 62.45% | - | - |
| Enterprise Value (EV) 1 | 6.794 | 36.73 | 46.68 | 89.3 | 43.46 | 26.06 | -42.14 |
| Change | - | 440.53% | 27.11% | 91.29% | -51.33% | -40.03% | -261.66% |
| P/E | -0.69x | -2.39x | -3.32x | -3.36x | -2.87x | -2.8x | -2.81x |
| PBR | - | - | - | - | 4.04x | 3.18x | - |
| PEG | - | 0.1x | -0.1x | 0.2x | -0.1x | -1x | 7.74x |
| Capitalization / Revenue | - | - | - | - | - | - | 13.1x |
| EV / Revenue | - | - | - | - | - | - | -3.81x |
| EV / EBITDA | - | - | - | -3.38x | -1.74x | -0.94x | 1.5x |
| EV / EBIT | -1.08x | -3.23x | -2.4x | -3.37x | -0.91x | -0.45x | 0.66x |
| EV / FCF | - | - | -2.67x | - | -1.03x | -0.76x | - |
| FCF Yield | - | - | -37.5% | - | -96.8% | -131% | - |
| Dividend per Share 3 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 3 | -3.84 | -2.16 | -3 | -2.354 | -3.319 | -3.412 | -3.399 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 11.05 |
| EBITDA 1 | - | - | - | -26.46 | -25 | -27.75 | -28 |
| EBIT 1 | -6.268 | -11.38 | -19.45 | -26.46 | -47.52 | -58.23 | -64.17 |
| Net income 1 | -8.368 | -11.69 | -19.65 | -24.87 | -49.92 | -65.51 | -79.41 |
| Net Debt 1 | - | - | -48.97 | - | -101.6 | -119 | -187.2 |
| Reference price 3 | 2.640 | 5.160 | 9.960 | 7.920 | 9.540 | 9.540 | 9.540 |
| Nbr of stocks (in thousands) | 3,483 | 9,399 | 13,818 | 15,459 | 21,216 | - | - |
| Announcement Date | 30/03/23 | 27/03/24 | 26/03/25 | 27/03/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MSCL Stock
- Valuation Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
